BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23000415)

  • 21. Variation of Benzo[
    Edwards SH; Hassink M; Taylor KM; Vu AT
    Chem Res Toxicol; 2023 Feb; 36(2):202-212. PubMed ID: 36638203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users.
    Stepanov I; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):885-91. PubMed ID: 15824160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of tobacco-specific N-nitrosamines and their metabolites and results of related bioassays.
    Amin S; Desai D; Hecht SS; Hoffmann D
    Crit Rev Toxicol; 1996; 26(2):139-47. PubMed ID: 8688157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation and analysis of tobacco-specific N-nitrosamines.
    Brunnemann KD; Prokopczyk B; Djordjevic MV; Hoffmann D
    Crit Rev Toxicol; 1996; 26(2):121-37. PubMed ID: 8688156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs).
    Back S; Masser AE; Rutqvist LE; Lindholm J
    BMC Chem; 2023 Mar; 17(1):9. PubMed ID: 36869349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of porphyrins to cigarette filters to reduce the levels of benzo[a]pyrene (B[a]P) and tobacco-specific N-nitrosamines (TSNAs) in mainstream cigarette smoke.
    Wang C; Dai Y; Feng G; He R; Yang W; Li D; Zhou X; Zhu L; Tan L
    J Agric Food Chem; 2011 Jul; 59(13):7172-7. PubMed ID: 21662235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
    Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
    J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends Over Time in Tobacco-Specific Nitrosamines (TSNAs) in Whole Tobacco and Smoke Emissions From Cigarettes Sold in Canada.
    Czoli CD; Hammond D
    Nicotine Tob Res; 2018 Apr; 20(5):649-653. PubMed ID: 28595283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tobacco-specific N-nitrosamines in dry snuff.
    Adams JD; Owens-Tucciarone P; Hoffmann D
    Food Chem Toxicol; 1987 Mar; 25(3):245-6. PubMed ID: 3570114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinogenic agents in snuff.
    Hoffmann D; Harley NH; Fisenne I; Adams JD; Brunnemann KD
    J Natl Cancer Inst; 1986 Mar; 76(3):435-7. PubMed ID: 3456461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.
    Stepanov I; Biener L; Yershova K; Nyman AL; Bliss R; Parascandola M; Hatsukami DK
    Nicotine Tob Res; 2014 Aug; 16(8):1070-8. PubMed ID: 24604020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tobacco-specific nitrosamines in new tobacco products.
    Stepanov I; Jensen J; Hatsukami D; Hecht SS
    Nicotine Tob Res; 2006 Apr; 8(2):309-13. PubMed ID: 16766423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tobacco-specific nitrosamines in the saliva of Inuit snuff dippers in the Northwest Territories of Canada.
    Brunnemann KD; Hornby AP; Stich HF
    Cancer Lett; 1987 Oct; 37(1):7-16. PubMed ID: 3664451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of air-curing environment on alkaloid-derived nitrosamines in burley tobacco.
    Andersen RA; Burton HR; Fleming PD; Hamilton-Kemp TR; Gay SL
    IARC Sci Publ; 1987; (84):451-5. PubMed ID: 3679420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
    Stepanov I; Jensen J; Hatsukami D; Hecht SS
    Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical analysis of snus products from the United States and northern Europe.
    Lawler TS; Stanfill SB; Tran HT; Lee GE; Chen PX; Kimbrell JB; Lisko JG; Fernandez C; Caudill SP; deCastro BR; Watson CH
    PLoS One; 2020; 15(1):e0227837. PubMed ID: 31940415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan.
    Idris AM; Nair J; Friesen M; Ohshima H; Brouet I; Faustman EM; Bartsch H
    Carcinogenesis; 1992 Jun; 13(6):1001-5. PubMed ID: 1600602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobacco-specific N-nitrosamines NNN and NNK levels in cigarette brands between 2000 and 2014.
    Gunduz I; Kondylis A; Jaccard G; Renaud JM; Hofer R; Ruffieux L; Gadani F
    Regul Toxicol Pharmacol; 2016 Apr; 76():113-20. PubMed ID: 26806560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines.
    Stanfill SB; Connolly GN; Zhang L; Jia LT; Henningfield JE; Richter P; Lawler TS; Ayo-Yusuf OA; Ashley DL; Watson CH
    Tob Control; 2011 May; 20(3):e2. PubMed ID: 21109685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine.
    Kavvadias D; Scherer G; Urban M; Cheung F; Errington G; Shepperd J; McEwan M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1185-92. PubMed ID: 19328751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.